microbiome

MaaT Pharma eyes Phase II after early success in ALS microbiome trial
Clinical Trials Arena
Tue, 11/26/24 - 11:23 am
MaaT Pharma
ALS
clinical trials
microbiome
MaaT-033
Seres Therapeutics’ SER-155 Shows Promising Clinical Results
Tip Ranks
Thu, 09/12/24 - 07:26 pm
Seres Therapeutics
microbiome
clinical trials
SER-155
stem cell transplant
Seres, indebted and in need of cash, agrees to sell microbiome pill to Nestle
BioPharma Dive
Thu, 06/6/24 - 11:46 am
Seres Therapeutics
microbiome
Nestle
C. difficile
Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health
Pharma Voice
Thu, 02/22/24 - 11:45 am
Ferring Pharmaceuticals
gene therapy
microbiome
bladder cancer
C. difficile
Microbiome-based treatment shows potential in graft-versus-host disease
Biopharma Reporter
Tue, 12/19/23 - 10:16 am
MaaT Pharma
microbiome
graft vs host disease
MaaT013
Beaten by placebo, Evelo seeks partner for once-lauded microbiome platform and programs
Fierce Biotech
Tue, 10/17/23 - 09:57 pm
Evelo Biosciences
microbiome
clinical trials
psoriasis
Viome, a microbiome startup, raises $86.5M, inks distribution deal with CVS
TechCrunch
Mon, 08/21/23 - 10:17 am
Viome
microbiome
CVS Health
Innovation in immuno-oncology: Leading companies in microbiota restoration therapy
Clinical Trials Arena
Mon, 05/8/23 - 10:37 am
immuno-oncology
microbiome
Solarea Bio Announces First Close of Series B Financing Round
BioSpace
Mon, 05/8/23 - 10:15 am
Solarea Bio
funding
microbiome
FDA approves first oral microbiome therapy Vowst
Fierce Pharma
Thu, 04/27/23 - 11:53 am
Seres Therapeutics
microbiome
Vowst
SER-109
C. difficile
FDA
The state of the oncology microbiome therapeutics pipeline at a glance
Clinical Trials Arena
Fri, 03/10/23 - 11:23 am
oncology
cancer
microbiome
drug development
Is MaaT back? After 18 months on hold, microbiome biotech sees end to impasse with FDA
Fierce Biotech
Fri, 02/3/23 - 10:55 am
MaaT Pharma
microbiome
FDA
fecal microbiome
MaaT013
Finch throws in the towel on microbiome journey, lets go of 77 employees
Endpoints
Tue, 01/24/23 - 10:23 am
Finch Therapeutics
layoffs
microbiome
This Week at FDA: FDA approves first FMT product, upcoming mpox guidance, and more
RAPS.org
Sun, 12/4/22 - 01:29 pm
FDA
regulatory
mpox
Ferring Pharmaceuticals
microbiome
COVID-19
Eli Lilly
FDA approves first fecal microbiome drug, setting stage for others
Stat
Thu, 12/1/22 - 10:41 am
Ferring Pharmaceuticals
Rebyota
FDA
C. difficile
fecal microbiome
microbiome
Concerto Biosciences Raises $23 Million in Series A to Advance Product Development, Expand Pipeline
BioSpace
Wed, 11/2/22 - 10:07 am
Concerto Biosciences
funding
microbiome
Seres one step closer to bringing first oral microbiome therapy to market as FDA mulls approval
Fierce Biotech
Wed, 10/26/22 - 10:51 am
Seres Therapeutics
microbiome
C. difficile
SER-109
Novome gets $43.5M boost for its engineered microbiome therapies
MedCity News
Tue, 09/13/22 - 08:01 pm
Novome Biotechnologies
funding
microbiome
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
FDA
Bristol Myers Squibb
deucravacitinib
Amylyx Pharmaceuticals
ALS
AMX0035
Ferring Pharmaceuticals
microbiome
RBX2660
Revance Therapeutics
Bluebird Bio
Spectrum Pharmaceuticals
JNJ
Oncopeptides
FDA declines to free MaaT's microbiome drug from clinical hold after a year
Fierce Biotech
Wed, 08/10/22 - 11:31 pm
MaaT Pharma
FDA
microbiome
clinical trials
graft vs host disease

Pages